Alport Syndrome Publications/Presentations

Mitrofanova A, Molina J, Varona Santos J, Guzman J, Morales XA, Ducasa GM, Bryn J, Sloan A, Volosenco I, Kim JJ, Ge M, Mallela SK, Kretzler M, Eddy S, Martini S, Wahl P, Pastori S, Mendez AJ, Burke GW, Merscher S, Fornoni A. Hydroxypropyl-β-cyclodextrin protects from kidney disease in experimental Alport syndrome and focal segmental glomerulosclerosis. Kidney Int. 2018 Oct 6. pii: S0085-2538(18)30518-0. doi: 10.1016/j.kint.2018.06.031. [Epub ahead of print]

Morales XA, Mitrofanova AV, David JM, Correa M, Pedigo C, Leclercq F, Varona Santos JT, Mercher S, Fornoni A. Cyclodextrin improves renal function in experimental alport syndrome. Poster presentation at the American Society of Nephrology Kidney Week, November 3-8, 2015, San Diego, CA.